Angelika Schütz

Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs—First real world data from Austria

Caroline Schmidbauer, Raphael Schubert, Angelika Schütz et al. · PLoS ONE · 2020 · 39 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct‐acting antivirals

Angelika Schütz, Stephan Moser, Cornelia Schwanke et al. · Journal of Viral Hepatitis · 2018 · 33 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease

Stephan Moser, K Kozbial, Hermann Laferl et al. · European Journal of Gastroenterology & Hepatology · 2017 · 19 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy

Caroline Schmidbauer, Michael Schwarz, Angelika Schütz et al. · PLoS ONE · 2021 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12